ITGB5 has been shown to contribute to tumor development in breast cancer, epithelial-mesenchymal transition and tumor potential in carcinoma cells [37, 38] and TAL1 is T-cell pro-oncogene with over-expression associated with development of leukemia. This evidence concerns the gene ITGB5 and leukemia.